LISRAYA
Live / Allowed — Notice of allowance issued (as of 16 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99507742
- Mark type
- Stylized text
- Filed
- 20 Nov 2025
- Published for opposition
- 21 Apr 2026
- Attorney of record
- Lisa L. Mueller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease
Owner
- PRIOVANT THERAPEUTICS, INC., Durham, NC, US
- PRIOVANT THERAPEUTICS, INC., NEW YORK, NY, US
Prosecution history
- 10 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
- 16 Jun 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 May 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 May 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 21 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Apr 2026 — PUBLISHED FOR OPPOSITION
- 15 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Mar 2026 — ASSIGNED TO EXAMINER
- 20 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 20 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Nov 2025 — NEW APPLICATION ENTERED